Literature DB >> 27305409

ANVISA APPROVES THE FIRST BIOSIMILAR MONOCLONAL ANTIBODY BASED ON COMPARABILITY IN BRAZIL.

Fábio Vieira Teixeira, Paulo Gustavo Kotze, Adérson Omar Mourão Cintra Damião.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27305409     DOI： 10.1590/S0004-28032016000200002

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN： 0004-2803


× No keyword cloud information.
  2 in total

Review 1.  Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America.

Authors:  Morton Scheinberg; Carlos Pineda; Gilberto Castañeda-Hernández; Juan José Zarbá; Aderson Damião; Luiz H Arantes; Ira Jacobs
Journal:  MAbs       Date:  2018-08-29       Impact factor: 5.857

2.  Biosimilar knowledge and viewpoints among Brazilian inflammatory bowel disease patients.

Authors:  Karoline Soares Garcia; Bianca Pocopetz Facas; Marta Brenner Machado; Fábio Vieira Teixeira; Luisa Avedano; Sanna Lönnfors; Rogério Saad Hossne; Laurent Peyrin-Biroulet; Natália Sousa Freitas Queiroz
Journal:  Therap Adv Gastroenterol       Date:  2021-05-18       Impact factor: 4.409
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.